Xigduo Tablet, Film Coated, Extended Release
Pricing Report NDC 0310-6260-30

Latest NADAC: $6.92047 per EA · Effective Feb 22, 2017 · Est. package price $207.61 (30 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Xigduo Xr (NDC 0310-6260-30) is $6.92047 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Feb 22, 2017.

As a a human prescription drug provided by Astrazeneca Pharmaceuticals Lp, this medication is distributed in a 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$6.92047
Per EA

Effective Date
Feb 22, 2017
Billable Units
30 EA
Estimated Package Price
$207.61
Data Status
As of May 31, 2017
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2015, the NADAC wholesale price for (NDC ) has moved within a range of $5.01492 to $9.60138 per EA. Over this 11 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$5.0149 - $9.6014
Market Volatility
91.46% Variance
Latest Trend
0.02%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Sep 23, 2026 $9.59236 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Aug 19, 2026 $9.59039 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $9.59302 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.59427 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.59427 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.59663 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.59660 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.60033 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.60138 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.59183 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.59183 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Nov 19, 2025 $9.58895 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026